Note: This article is for educational purposes only and should not replace medical advice. If you take Stelara and are pregnant, planning a pregnancy, breastfeeding, or thinking about breastfeeding, talk with your gastroenterologist, dermatologist, rheumatologist, obstetrician, or maternal-fetal medicine specialist before making medication changes.
Introduction: When a Positive Pregnancy Test Meets a Biologic Medication
Pregnancy has a special talent for turning ordinary questions into high-stakes detective work. Can you eat this cheese? Is that tea safe? Why does every smell suddenly have a personality? And if you take Stelara, the questions can feel even bigger: Is Stelara safe during pregnancy? Can you keep taking it while breastfeeding? Could it affect your baby’s vaccines? Should you stop, switch, pause, panic, or simply call your doctor before spiraling into the internet rabbit hole?
Stelara, the brand name for ustekinumab, is a biologic medication used to treat inflammatory conditions such as plaque psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis. It works by targeting interleukin-12 and interleukin-23, two immune-system proteins involved in inflammation. In plain English, Stelara helps turn down an immune response that has been acting like a smoke alarm at a barbecue.
The challenge is that pregnancy also involves the immune system, and decisions about biologic medications require balance. On one side, you want to avoid unnecessary exposure. On the other, uncontrolled inflammatory disease during pregnancy can create real risks for both parent and baby. That is why the best answer is rarely “always stop” or “never worry.” The better answer is: understand the evidence, know the key questions, and make a plan with your healthcare team.
What Is Stelara?
Stelara is a prescription biologic medicine. Unlike many traditional drugs made from small chemical compounds, biologics are large protein-based therapies designed to target specific parts of the immune system. Ustekinumab blocks IL-12 and IL-23, which are involved in inflammatory pathways.
Conditions Stelara May Treat
Depending on a person’s diagnosis and medical history, Stelara may be prescribed for:
- Moderate to severe plaque psoriasis
- Active psoriatic arthritis
- Moderately to severely active Crohn’s disease
- Moderately to severely active ulcerative colitis
For many people, Stelara is not a “nice little extra.” It may be the treatment that keeps painful flares, bowel symptoms, skin plaques, fatigue, joint pain, or steroid use under control. That matters during pregnancy because disease control is not cosmetic; it is part of protecting maternal and fetal health.
Stelara and Pregnancy: What the Evidence Suggests
Current human data on ustekinumab exposure during pregnancy are more reassuring than they once were, although researchers still want larger and longer studies. Pregnancy information for biologics has historically been limited because pregnant people are often excluded from clinical trials. As a result, much of what doctors use comes from pregnancy registries, observational studies, case reports, postmarketing experience, and disease-specific research.
Does Stelara Increase the Risk of Birth Defects?
Available research has not shown a clear increased risk of major birth defects with ustekinumab exposure during pregnancy. This is important because every pregnancy begins with a background risk of birth defects, even when no medication is used. The question is not whether risk exists at all, but whether Stelara appears to raise that baseline risk. Based on current published data, no strong signal suggests that it does.
That said, “reassuring” does not mean “guaranteed.” Medicine does not hand out guarantees, which is rude but honest. The decision to continue Stelara during pregnancy depends on your condition, disease severity, previous flares, other treatment options, timing of doses, and your healthcare provider’s judgment.
Does Stelara Increase the Risk of Miscarriage?
Studies so far have not found that ustekinumab clearly increases the chance of miscarriage. Miscarriage is common and can happen for many reasons, including chromosomal changes, underlying health conditions, age, and factors unrelated to medication. If you become pregnant while taking Stelara, do not stop it suddenly out of fear. Call your healthcare provider and review the situation carefully.
Why Disease Control Matters During Pregnancy
For people with Crohn’s disease, ulcerative colitis, psoriasis, or psoriatic arthritis, active inflammation can be more than uncomfortable. Inflammatory bowel disease flares during pregnancy may be associated with complications such as poor nutrition, anemia, corticosteroid use, hospitalization, preterm birth, or low birth weight. Severe psoriasis or uncontrolled arthritis can also affect sleep, stress, mobility, pain levels, and overall health.
This is why many specialists focus on one major goal before conception: get the disease stable first. Pregnancy is not the ideal season for a medical cliffhanger. If Stelara has been working well, your doctor may decide that continuing treatment is safer than risking a flare.
Should You Stop Stelara Before Getting Pregnant?
Do not stop Stelara on your own before trying to conceive. This is one of those “please do not freestyle” moments. Your doctor may recommend continuing, spacing doses, adjusting timing, switching therapies, or monitoring more closely. The right approach depends on your diagnosis and how your body has behaved in the past.
Questions to Ask Before Conception
- Is my disease in remission or well controlled?
- How long should I be stable before trying to conceive?
- Should I continue Stelara through pregnancy?
- Should dose timing change in the third trimester?
- What symptoms should I report immediately?
- Do I need a high-risk obstetrician or maternal-fetal medicine specialist?
- How will this affect my baby’s vaccine schedule?
These questions help your team create a plan before pregnancy begins. A plan is much better than a 2 a.m. search history that includes “Stelara pregnancy help” and “can stress give me heartburn or is this baby already dramatic.”
Placental Transfer: Why Timing Matters
Stelara is an IgG1 monoclonal antibody. Medications in this category can cross the placenta, especially later in pregnancy. Placental transfer is generally lower in the first trimester and increases as pregnancy progresses, particularly in the second and third trimesters.
This does not automatically mean harm. It means doctors may think carefully about timing, especially as delivery approaches. Some specialists may continue Stelara through pregnancy to maintain remission. Others may time the final pregnancy dose based on disease control, dosing schedule, and expected delivery date. The key is individualization.
Stelara and Breastfeeding
Many parents also ask, Can I breastfeed while taking Stelara? Current lactation information is generally reassuring, but still limited. Ustekinumab is a large protein molecule, so only small amounts are expected to pass into breast milk. Even if tiny amounts reach milk, the infant’s digestive system is expected to break down much of the protein, making absorption into the baby’s bloodstream unlikely to be high.
Published lactation data have found ustekinumab to be undetectable or present at very low levels in breast milk in many cases. Many infants have been breastfed during maternal treatment without clear medication-related harm reported. However, newborns and premature infants may need extra caution because their digestive systems and immune systems are still developing.
Should You Delay Restarting Stelara After Delivery?
If Stelara was paused during pregnancy, some experts suggest that waiting briefly after birth before restarting may reduce early transfer through breast milk. However, this is not a universal rule. For someone at high risk of a postpartum flare, restarting promptly may be more important. Postpartum flares can be physically and emotionally exhausting, especially when paired with sleep deprivation and a baby who believes 3 a.m. is a social hour.
Talk with your doctor about the timing that fits your condition. The decision should consider your flare history, disease severity, breastfeeding goals, delivery recovery, and whether you used Stelara late in pregnancy.
Stelara and Fertility
There is no strong evidence that Stelara reduces fertility. Studies have not clearly shown that ustekinumab makes it harder to get pregnant. For men or sperm-producing partners taking ustekinumab, available data have not shown a clear increase in birth defects or miscarriage related to paternal exposure.
Still, fertility is complicated. Active inflammatory disease, stress, poor nutrition, anemia, pain, and other medications may affect reproductive health. If pregnancy is taking longer than expected, do not assume Stelara is the villain wearing a tiny cape. Ask your clinician whether your disease activity, medication list, age, cycle patterns, or partner factors should be evaluated.
Stelara, Infant Vaccines, and Live Vaccines
One of the most practical issues after Stelara exposure during pregnancy is infant vaccination. Because ustekinumab can cross the placenta, especially later in pregnancy, babies exposed in utero may have some medication in their system at birth.
Non-live vaccines are generally handled according to routine pediatric guidance, but live vaccines require special discussion. In the United States, the live vaccine most commonly relevant in early infancy is the rotavirus vaccine. Some guidance recommends waiting six months after birth before giving live vaccines to infants exposed to ustekinumab in the womb, unless the baby’s doctor determines that earlier vaccination is appropriate based on timing of exposure, infant drug levels, and risk-benefit considerations.
Tell your baby’s pediatrician if you used Stelara during pregnancy. Do not assume the pediatrician automatically knows. Newborn paperwork is mighty, but it is not telepathic.
Possible Side Effects of Stelara to Keep in Mind
Stelara affects the immune system, so infection risk is an important consideration. Common side effects may include upper respiratory symptoms, headache, fatigue, injection-site reactions, nausea, vomiting, sinus symptoms, bronchitis, urinary tract infections, or diarrhea. Serious but less common risks may include serious infections, allergic reactions, certain malignancies, noninfectious pneumonia, and rare neurologic conditions.
During pregnancy or breastfeeding, call your healthcare provider promptly if you develop fever, persistent cough, shortness of breath, painful urination, severe headache, vision changes, unusual weakness, worsening diarrhea, blood in the stool, severe abdominal pain, or signs of an allergic reaction.
Practical Planning Tips for Pregnancy While Taking Stelara
1. Build a Team Early
Your care may involve an obstetrician, maternal-fetal medicine specialist, gastroenterologist, dermatologist, rheumatologist, pediatrician, and pharmacist. Yes, that sounds like the cast list of a medical drama, but coordinated care helps prevent confusion.
2. Review All Medications
Do not focus only on Stelara. Review supplements, over-the-counter medicines, steroids, pain relievers, topical treatments, antibiotics, and other immune therapies. Sometimes the medication that gets the most attention is not the one that needs the most adjustment.
3. Track Disease Activity
Keep a simple symptom record. For IBD, note bowel frequency, bleeding, pain, weight changes, appetite, and fatigue. For psoriasis, track skin flares, itching, cracking, and infections. For psoriatic arthritis, record joint swelling, morning stiffness, and mobility. Good notes help your doctor spot trouble early.
4. Avoid Sudden Medication Changes
Stopping Stelara suddenly may increase the risk of disease flare. A flare may require corticosteroids, hospitalization, or treatment changes that could carry their own pregnancy considerations. Medication decisions should be boringly planned, not dramatically improvised.
5. Talk About Delivery and Postpartum Care
Ask whether your condition affects delivery planning. Some people with Crohn’s disease, especially those with active perianal disease, may need special delivery discussions. Also ask about postpartum flare prevention, breastfeeding support, sleep, nutrition, and mental health. The postpartum period is not just “after the baby.” It is a full medical chapter.
What If You Accidentally Took Stelara Before Knowing You Were Pregnant?
First, breathe. Many people take medications before they know they are pregnant. If you used Stelara shortly before conception or during early pregnancy, contact your healthcare provider. Do not assume the worst. Early pregnancy exposure does not automatically mean harm, and available data have not shown a clear increase in major pregnancy risks.
Your doctor may review when your last dose occurred, your dosing schedule, how active your disease is, and whether continuing treatment is appropriate. In many cases, the bigger risk may be uncontrolled disease rather than the medication itself.
Stelara Compared With Other Biologics During Pregnancy
Some biologics have more pregnancy data than others. Anti-TNF medications, for example, have been studied for longer in inflammatory bowel disease and rheumatology. Ustekinumab has less pregnancy data than some older biologics, but evidence is growing and has become increasingly reassuring.
Switching from Stelara to another biologic just because pregnancy is planned is not always wise. If Stelara is controlling your disease and previous medications failed, changing therapy could cause a flare. On the other hand, if you are not responding well to Stelara, your doctor may discuss alternatives before conception. The best medication during pregnancy is often the one that safely keeps your disease quiet.
Experiences and Real-Life Scenarios: What Patients Often Navigate
The following examples are realistic, experience-based scenarios, not personal medical advice or stories about specific individuals. They show the kinds of conversations people often have when Stelara, pregnancy, breastfeeding, and family planning overlap.
The Planner: “I Want to Try for a Baby Next Year”
A person with Crohn’s disease has been in remission on Stelara for 18 months and wants to start trying to conceive next year. Their instinct is to stop medication “to be clean” before pregnancy. Their gastroenterologist explains that the goal is not to win a medication purity contest; the goal is a healthy pregnancy with controlled disease. Together, they review labs, inflammation markers, nutrition, iron levels, vaccination status, and timing of Stelara injections. The plan may be to continue treatment, monitor closely, and coordinate with an obstetrician before conception. The patient leaves with a checklist instead of a panic cloud.
The Surprise: “I Just Found Out I’m Pregnant”
Another person takes a Stelara dose and discovers two weeks later that they are pregnant. The first reaction is fear. They wonder if they have already done something wrong. Their doctor reassures them that many pregnancies involve early medication exposure before pregnancy is known. Instead of stopping immediately, they review disease control and discuss benefits and risks. The patient learns that untreated inflammation can also be risky. The next steps include confirming gestational age, notifying all relevant providers, and making a dose plan for the rest of pregnancy.
The Breastfeeding Question: “Can I Nurse My Baby?”
A new parent with ulcerative colitis wants to breastfeed but worries because Stelara may pass into milk. Their clinician explains that ustekinumab is a large protein and is expected to transfer into breast milk in small amounts. The baby’s digestive tract is also likely to break down much of it. Because the parent has a history of severe postpartum flares, staying controlled matters. Together, they choose a breastfeeding plan with pediatric follow-up. The parent is reminded to report infections, feeding problems, poor weight gain, or unusual symptoms, while also being reassured that breastfeeding may still be possible.
The Vaccine Conversation: “Why Does the Pediatrician Need to Know?”
A baby was exposed to Stelara during the third trimester. At the first pediatric appointment, the parents mention the medication. This helps the pediatrician review live vaccine timing, especially rotavirus. The pediatrician may coordinate with the parent’s specialist if there is uncertainty. This conversation is simple but important. It prevents a vaccine decision from being made without the full picture.
The Emotional Side: “I Feel Guilty Either Way”
Many people feel trapped between two worries: taking medication and risking exposure, or stopping medication and risking a flare. That guilt can be heavy. But needing treatment during pregnancy is not a failure. Chronic inflammatory disease does not politely step aside because someone is building a nursery. A good care plan respects both the baby’s safety and the parent’s health. The healthiest choice is often the one that keeps inflammation controlled, reduces emergency interventions, and supports the parent through pregnancy, delivery, and the postpartum months.
Conclusion
Stelara and pregnancy is not a one-size-fits-all topic. Current evidence is generally reassuring, especially when weighed against the risks of uncontrolled inflammatory disease. Ustekinumab has not been clearly linked to increased miscarriage or major birth defect risk in available studies, and breastfeeding data suggest low transfer into milk with minimal expected infant absorption. Still, decisions should be individualized.
If you are pregnant, planning pregnancy, breastfeeding, or preparing to breastfeed while taking Stelara, the best next step is a calm, coordinated conversation with your healthcare team. Ask about disease control, dose timing, infant vaccines, postpartum flare prevention, and breastfeeding goals. In pregnancy, the goal is not perfection. The goal is smart risk management, steady disease control, and a care plan that does not rely on late-night internet panic as its primary strategy.
